Sampling strategies to detect anthelmintic resistance: the perspective of human onchocerciasis

Trends in Parasitology

Volumn 25, Issue 1, 2009, Pages 11-17

  Churcher, Thomas S ^a   Basáñez, María Gloria ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IVERMECTIN; PRAZIQUANTEL;

ARTICLE; DRUG RESISTANCE; DRUG SENSITIVITY; DRUG TREATMENT FAILURE; GENETIC VARIABILITY; LIFE CYCLE; MATHEMATICAL MODEL; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PARASITE CONTROL; SAMPLING; SCHISTOSOMIASIS;

ADOLESCENT; ADULT; ANIMALS; ANTHELMINTICS; CHILD; DRUG RESISTANCE; HOST-PARASITE INTERACTIONS; HUMANS; MIDDLE AGED; ONCHOCERCA; ONCHOCERCIASIS; YOUNG ADULT;

EID: 58149136267     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2008.09.011     Document Type: Article

References (48)

1. Molyneux D.H. Control of human parasitic diseases: context and overview. Adv. Parasitol. 61 (2006) 1-45
2. Horton J. Global anthelmintic chemotherapy programs: learning from history. Trends Parasitol. 19 (2003) 405-409
3. Cotreau M.M., et al. The antiparasitic moxidectin: safety, tolerability, and pharmacokinetics in humans. J. Clin. Pharmacol. 43 (2003) 1108-1115
4. Dadzie Y., et al. Final report of the conference on the eradicability of onchocerciasis. Filaria J. 2 (2003) 2
5. De Clercq D., et al. Failure of mebendazole in treatment of human hookworm infections in the southern region of Mali. Am. J. Trop. Med. Hyg. 57 (1997) 25-30
6. Albonico M., et al. Efficacy of mebendazole and levamisole alone or in combination against intestinal nematode infections after repeated targeted mebendazole treatment in Zanzibar. Bull. World Health Organ. 81 (2003) 343-352
7. Albonico M., et al. Development of the egg hatch assay for detection of anthelminthic resistance in human hookworms. Int. J. Parasitol. 35 (2005) 803-811
8. Reynoldson J.A., et al. Failure of pyrantel in treatment of human hookworm infections (Ancylostoma duodenale) in the Kimberley region of north west Australia. Acta Trop. 68 (1997) 301-312
9. Eberhard M.L., et al. Evidence of non-susceptibility to diethylcarbamazine in Wuchereria bancrofti. J. Infect. Dis. 163 (1991) 1157-1160
10. Eberhard M.L., et al. Persistence of microfilaremia in bancroftian filariasis after diethylcarbamazine citrate therapy. Trop. Med. Parasitol. 39 (1988) 128-130
11. ® (ivermectin) in the treatment of human onchocerciasis. Acta Trop. 84 (2002) 49-53
12. Awadzi K., et al. Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann. Trop. Med. Parasitol. 98 (2004) 359-370
13. Awadzi K., et al. An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann. Trop. Med. Parasitol. 98 (2004) 231-249
14. Osei-Atweneboana M.Y., et al. Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study. Lancet 369 (2007) 2021-2029
15. Remme J.H.F., et al. Efficacy of ivermectin against Onchocerca volvulus in Ghana. Lancet 370 (2007) 1123-1124
16. Jackson F., and Coop R. The development of anthelmintic resistance in sheep nematodes. Parasitology 120 (2000) S95-S107
17. Albonico M., et al. Molecular analysis of the β-tubulin gene of human hookworms as a basis for possible benzimidazole resistance on Pemba Island. Mol. Biochem. Parasitol. 134 (2004) 281-284
18. Ardelli B.F., et al. Characterization of a half-size ATP-binding cassette transporter gene which may be a useful marker for ivermectin selection in Onchocerca volvulus. Mol. Biochem. Parasitol. 145 (2006) 94-100
19. Ardelli B.F., and Prichard A.K. Reduced genetic variation of an Onchocerca volvulus ABC transporter gene following treatment with ivermectin. Trans. R. Soc. Trop. Med. Hyg. 101 (2007) 1223-1232
20. Bourguinat C., et al. P-glycoprotein-like protein, a possible genetic marker for ivermectin resistance selection in Onchocerca volvulus. Mol. Biochem. Parasitol. 158 (2008) 101-111
21. Eng J.K., et al. Ivermectin selection on β-tubulin: evidence in Onchocerca volvulus and Haemonchus contortus. Mol. Biochem. Parasitol. 150 (2006) 229-235
22. Schwab A.E., et al. Detection of benzimidazole resistance-associated mutations in the filarial nematode Wuchereria bancrofti and evidence for selection by albendazole and ivermectin combination treatment. Am. J. Trop. Med. Hyg. 73 (2005) 234-238
23. Schwenkenbecher J.M., et al. Characterization of β-tubulin genes in hookworms and investigation of resistance-associated mutations using real-time PCR. Mol. Biochem. Parasitol. 156 (2007) 167-174
24. Anderson R.M., and May R.M. Infectious Disease in Humans: Dynamics and Control (1991), Oxford University Press
25. Dalton P.R., and Pole D. Water-contact patterns in relation to Schistosoma haematobium infection. Bull. World Health Organ. 56 (1978) 417-426
26. Duerr H.P., et al. On the interpretation of age-intensity profiles and dispersion patterns in parasitological surveys. Parasitology 126 (2003) 87-101
27. Filipe J.A.N., et al. Human infection patterns and heterogeneous exposure in river blindness. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 15265-15270
28. Woolhouse M.E. Patterns in parasite epidemiology: the peak shift. Parasitol. Today 14 (1998) 428-434
29. Schwab A.E., et al. An analysis of the population genetics of potential multi-drug resistance in Wuchereria bancrofti due to combination chemotherapy. Parasitology 134 (2007) 1025-1040
30. Van Wyk J.A. Refugia - overlooked as perhaps the most potent factor concerning the development of anthelmintic resistance. Onderstepoort J. Vet. Res. 68 (2001) 55-67
31. Basáñez M.-G., et al. Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis. Lancet Infect. Dis. 8 (2008) 310-322
32. Churcher T.S., and Basáñez M.-G. Density dependence and the spread of anthelmintic resistance. Evolution Int. J. Org. Evolution 62 (2008) 528-537
33. Basáñez M.-G., and Ricárdez-Esquinca J. Models for the population biology and control of human onchocerciasis. Trends Parasitol. 17 (2001) 430-438
34. Gómez-Priego A., et al. Prevalence of antibodies to Onchocerca volvulus in residents of Oaxaca, Mexico, treated for 10 years with ivermectin. Clin. Diagn. Lab. Immunol. 12 (2005) 40-43
35. Guevara A.G., et al. Entomological evaluation by pool screen polymerase chain reaction of Onchocerca volvulus transmission in Ecuador following mass Mectizan distribution. Am. J. Trop. Med. Hyg. 68 (2003) 222-227
36. Rodríguez-Pérez M.A., et al. Large-scale entomologic assessment of Onchocerca volvulus transmission by poolscreen PCR in Mexico. Am. J. Trop. Med. Hyg. 74 (2006) 1026-1033
37. Wolstenholme A.J., et al. Drug resistance in veterinary helminths. Trends Parasitol. 20 (2004) 469-476
38. Plaisier A.P., et al. Irreversible effects of ivermectin on adult parasites in onchocerciasis patients in the Onchocerciasis Control Programme in West Africa. J. Infect. Dis. 172 (1995) 204-210
39. Anderson T.J.C., et al. Population biology of parasitic nematodes: applications of genetic markers. Adv. Parasitol. 41 (1998) 219-283
40. Elard L., and Humbert J.F. Importance of the mutation of amino acid 200 of the isotype 1 β-tubulin gene in the benzimidazole resistance of the small-ruminant parasite Teladorsagia circumcincta. Parasitol. Res. 85 (1999) 452-456
41. Le Jambre L.F., et al. The inheritance of thiabendazole resistance in Haemonchus contortus. Parasitology 78 (1979) 107-119
42. Prichard R.K. Genetic variability following selection of Haemonchus contortus with anthelmintics. Trends Parasitol. 17 (2001) 445-453
43. Martin P.J., et al. Detecting benzimidazole resistance with faecal egg count reduction tests and in vitro assays. Aust. Vet. J. 66 (1989) 236-240
44. Churcher T.S., et al. An analysis of genetic diversity and inbreeding in Wuchereria bancrofti: implications for the spread and detection of drug resistance. PLoS Negl. Trop. Dis. 2 (2008) e211
45. Criscione C.D., et al. Molecular ecology of parasites: elucidating ecological and microevolutionary processes. Mol. Ecol. 14 (2005) 2247-2257
46. Duerr H.P., et al. Determinants of the eradicability of filarial infections: a conceptual approach. Trends Parasitol. 21 (2005) 88-96
47. Macdonald G. The dynamics of helminth infections, with special reference to schistosomes. Trans. R. Soc. Trop. Med. Hyg. 59 (1965) 489-506
48. Churcher, T.S. et al. Mass treatment of parasitic disease: implications for the development and spread of anthelmintic resistance. In Antimicrobial Drug Resistance (Weber, T.J., ed). Issues in Infectious Diseases Series, S. Karger AG, Basel, Switzerland (in press)